Exact Sciences Corp (NAS:EXAS)
$ 49.84 -4.24 (-7.84%) Market Cap: 9.20 Bil Enterprise Value: 11.10 Bil PE Ratio: 0 PB Ratio: 2.93 GF Score: 80/100

Exact Sciences Corp at Cowen Health Care Conference Transcript

Mar 11, 2019 / 06:50PM GMT
Release Date Price: $90.85 (+6.42%)
Doug Schenkel
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

All right. We're good to go? All right. Thank you. All right. Good afternoon, everyone. It's my pleasure to welcome Jeff Elliott, Exact Sciences' Chief Financial Officer, to the Cowen conference. Exact Sciences had, by all measures, another great year in 2018. Sales grew over 70%. Volumes grew over 60%. You added almost 50,000 new ordering practices. And you entered into a great partnership, at least in our opinion, with Pfizer. So we believe -- we continue to believe Exact is a great company and a great stock. It also happens to continue to be one of our top diagnostic and lab techs for this year.

So with that, let me just -- well, first off, thanks again for being here, Jeff.

Jeffrey T. Elliott
Exact Sciences Corporation - CFO

Yes, Doug. Thanks for having me. It's really good to be back here at Cowen again.

Doug Schenkel
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

So just to give

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot